TIMP2 and neoplasm: It stimulates the expression of the tissue inhibitor of metalloproteinases 2 (TIMP2); inhibits angiogenesis; interferes with the mechanisms of resistance, tumor progression and metastasis; reprograms glucose and lipid metabolism; and reduces the level of tumor-induced proinflammatory cytokines, i.e., modulates the tumor microenvironment [21,22].